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Abstract
The subject of analysis is a non-linear three-compartment model, widely used in phar-
macological absorption studies. It has been transformed into a general form, thus leading
automatically to an appropriate approximation. This made the absorption profile accessi-
ble and expressions for absorption times, apparent permeabilities and equilibrium values
were given. These findings allowed a profound analysis of results from non-linear curve
fits and delivered the dependencies on the systems’ parameters over a wide range of values.
The results were applied to an absorption experiment with multidrug transporter-affected
antibiotic CNV97100 on Caco-2 cell monolayers.
Key words: absorption kinetics, eﬄux mechanisms, non-linear absorption,
three-compartment model, Michaelis-Menten
1 Introduction
Orally administered drugs are mainly absorbed by the small intestine; they are me-
diated upon by a variety of processes (Hunter and Hirst, 1997). The drug passes
from the lumen through the epithelial cells and the lamina propria into the blood
stream (fig. 1 (left)). On its way it can be metabolised, transported away from the
tract where absorption is possible or accumulate in organs other than those of treat-
ment.
Much experimental activity aimed at analysing the kinetic aspects of the process of
drug absorption has been pursued recently. For better control, a variety of in-vitro
methods of drug absorption have been developed (Balimane et al., 2000). Epithelial
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Fig. 1. schematic view of: intestinal wall with microvilli and a capillary embedded in the
lamina propria (left); epithelial cells on filter (middle); simplified mathematical model with
eﬄux pump indicated on apical side (right)
cell cultures can be seeded in a mono-layer, forming the contact surface between
two chambers (fig. 1 (middle)) and concentrations of an applied drug can be mea-
sured over time in both chambers. Two of the well-known cell culture models are
Caco-2 cells (Artursson and Borchardt, 1997; Artursson et al., 2001) and MDCK
cells (Irvine et al., 1999).
Apart from a fundamental interest in understanding the basic mechanisms by which
a drug is assimilated by the human body, the kinetics of drug absorption is also a
topic of much practical interest. Detailed knowledge of this process, resulting in the
prediction of the drug absorption profile, can be of much help in drug development
stage (Eddershaw et al., 2000; Zhou, 2003). To this end, several kinetic models for
drug absorption within the body have been established (see e.g. (Yu and Amidon,
1999)). In this paper we analyse in detail a previously developed model, belonging
to the category of the so-called three-compartment models (Skinner et al., 1959;
Kramer et al., 1974) in which substances move between three volumes (e.g. the
human organs) and active pumps are modelled by terms of non-linear fluxes. We
will provide an analytical solution to an (adequate) approximation of the model,
which facilitates analysis of the absorption characteristics as a whole without re-
quiring repetitive numerical integration of the differential equations. This facilitates
a fast and easy insight into how physiologically meaningful parameters influence
quantities available from experiment in three-compartment models.
The paper is organised as follows: After introducing the model and presenting its
solution in section 2, we discuss the results and apply them to an antibiotic ab-
sorption study carried out with the compound CNV97100 on Caco-2 cell cultures
(section 3). Conclusions are found in section 4. Details of the mathematical proce-
dure are summarised in the Appendix.
2 The model and its theoretical treatment
Compartment models describe the behaviour of solutions or emulsions in connected
volumes by analysing the molecule flux between them and all sources and sinks.
When applied to drug absorption some specific simplifications must be made: Here
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it is considered that two volumes (e.g. gastrointestinal lumen and blood plasma in-
vivo or apical and basolateral chamber in-vitro) are connected through a third, in-
vitro: cellular, volume. The absorbed substance should have low lipophilicity such
that the unstirred water layer can be neglected. Furthermore it is assumed that the
compound does not ionise and that the concentrations in the different intestinal cells
of the mono-layer are equal (which is exact only if all cells have the same param-
eters). With these assumptions the absorption can be seen as a transport from one
large volume to another through a third (the cellular) volume (Gonzalez-Alvarez
et al., 2005). Figure 1 (right) sketches the simplifications of the model. There is
no spatial dependency and molecules can pass through the two cell membranes.
The overall amount of drug molecules is considered to be constant, a hypothesis
that assumes a closed system and that metabolism does not occur. For an in-vitro
experiment of short duration this is a reasonable assumption.
Passive transport across the membrane is mediated, to a first approximation, by
the concentration gradients according to Fick’s law (Fick, 1855), which specifies a
linear relation between the flux of particles and the concentration gradient. When
passive absorption is accompanied by energy-consuming eﬄux transporters, it is
represented by a non-linear function term in kinetic transport equations. A variety
of transporter types could be involved in the absorption of the molecules. In our
work we consider that the non-linear transporters are present only on one (the api-
cal) cell membrane, but our results could be extended directly to the case that those
transporters are located on the basolateral membrane (or even in both membranes).
Incorporating both linear and non-linear terms, the time evolution of the amount of
diluted molecules (QA/C/B) in the three compartments can be described as follows:
dQA(t)
dt
= +ClAC
(
QC
VC
− QA
VA
)
+J (1a)
dQC(t)
dt
= −ClAC
(
QC
VC
− QA
VA
)
− J −ClCB
(
QC
VC
− QB
VB
)
(1b)
dQB(t)
dt
= +ClCB
(
QC
VC
− QB
VB
)
(1c)
Q0 = QA + QB + QC, (1d)
where equation (1d) stands for conservation of the overall molecule number, Q0.
The indices denote the corresponding compartment (Apical, Cellular, Basolateral),
VA/C/B are the respective volumes. The apical, cellular and basolateral concentra-
tions are given respectively by a = QA/VA, c = QC/VC and b = QB/VB. The passive,
linear, diffusion terms are proportional to the concentration difference, being ClAC
and ClCB the clearances indexed with their respective membrane index. In the equa-
tions, J represents the non-linear contribution due to specific eﬄux transporters.
As it is an energy-consuming process, this can happen both along or against the
gradient.
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In the appendix we will introduce an equivalent way of writing these kinetic equa-
tions (1) that will demonstrate its formal similarity with some problems in the field
of mechanics. This mechanical analogy will invite some approximations, consist-
ing in a linearisation of (1), allowing us to find explicit solutions for the evolution
of the number of molecules on each compartment. If approximated this way, any
mass-conserving, three-compartment-model will result in a sum of three exponen-
tials, independent from the exact form of non-linearity:
QA(t) = Q
eq
A − A1e−t/t1 − A2e−t/t2 − A3e−t/t3 (2a)
QB(t) = Q
eq
B − B1e−t/t1 − B2e−t/t2 − B3e−t/t3 (2b)
QC(t) = Q
eq
C −C1e−t/t1 −C2e−t/t2 −C3e−t/t3 (2c)
where t1, t2 and t3 define three time-scales and Q
eq
A , Q
eq
B and Q
eq
C are the equilib-
rium asymptotic quantities of the diluted substance in each compartment. These
and the constants (A/B/C)(1/2/3) adopt different expressions, depending on the non-
linearity. If given a specific expression for the non-linear transport terms and numer-
ical values for the parameters, one can calculate the above constants and compare
the result with the numerical integration of the non-linear system (1) or with experi-
mental data. This explicit type of solution for a Michaelis-Menten flux J constitutes
one of the main results of this paper and is the basis for the subsequent analysis.
In section 3 we will carry out this program explicitly for the model and data taken
from (Gonzalez-Alvarez et al., 2005), resulting in parameters as given in table 4.
Experimentally, it is rare to measure the complete variation of QA(t), QB(t) and
QC(t) with respect to time. A typical experiment (Lentz et al., 2000; Ruiz-Garcia
et al., 2002; Faassen et al., 2003; Balimane et al., 2004; Gonzalez-Alvarez et al.,
2005) starts by placing an initial concentration C0 of a drug in either the apical or in
the basolateral compartment. The so-called apparent permeability Papp =
dQ/dt
S C0
,
with Q(t) the amount of material on the receiving side, is measured in both direc-
tions and the values are compared.
The explicit solution Eqs.(2) identifies three different characteristic time scales, t1,
t2 and t3, within the evolution of these concentrations. Each one of them separates
well defined regimes in the evolution of the concentrations: if time is much smaller
than the characteristic time scale, the corresponding exponential term comes close
to being linear; it changes exponentially at times close to it and is almost constant at
much larger times. This information helps the experimenter to decide if the chosen
sampling interval is adequate or not. Furthermore, it is mathematically possible to
observe oscillatory behaviour in the presented system, if one of the t1,2,3 is complex.
The condition for this to happen is shown in the appendix.
We would like to stress that our way of approximating the problem has allowed us
to identify these natural time scales and to find their relationship to other constants
that are experimentally accessible. It appears that in many cases (one example in
the next section and table 1) one time-scale (t2) is much smaller than the inter-
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val between measurements. Measurements of the apparent permeability are usu-
ally carried out within a time frame of between 15-30 min and a couple of hours
(Gonzalez-Alvarez et al., 2005; Lentz et al., 2000; Yamashita et al., 2000), whereas
t2 seems to be of the order of a few minutes. Hence, measurement times satisfy
t  t2 and the exponential term e−t/t2 can be neglected. Analysis of the experiments
(Gonzalez-Alvarez et al., 2005) indicates that transport is mediated by transporters
with an intracellular binding site. In this case, and according to table 1, both t1 and
t3 are much larger than the measurement times, allowing us to perform the linear
approximations e−t/t1 ≈ 1 − t/t1 and e−t/t3 ≈ 1 − t/t3 to obtain explicit expressions
for the apparent permeability:
PappBA =
1
S C0
(
A1
t1
+
A3
t3
)
(3)
in the case that the drug is initially delivered in the basolateral side, and
PappAB =
1
S C0
(
B1
t1
+
B3
t3
)
(4)
when the drug is delivered in the apical side. It seems that even in the case of very
fast-absorbing drugs (tested for permeabilities such as those in (Korjamo et al.,
2007)) times are well separated into those of around an hour and those of less than
a minute (data not shown). However, when it occurs that the time scales are all of a
similar order, one can easily extend eqs. 3 and 4 by the required term.
Absorption of many drugs (Raviv et al., 1990) is seriously limited by P-glyco-
protein (P-gp), the multidrug transporter. This particular protein is expressed on the
apical membrane of intestinal epithelium cells (Troutman and Thakker, 2003a,b;
Ruiz-Garcia et al., 2002). The molecule to be transported must bind with the pro-
tein and will then be “flipped” (Hunter and Hirst, 1997) onto the other side of the
membrane, where it is no longer available for the “reaction”. This makes its dy-
namics similar to enzyme reactions and is often represented by the sigmoid shape
of a Michaelis-Menten-reaction rate (Michaelis and Menten, 1913):
J(QC) = S VMQC/VCKM + QC/VC . (5)
VM determines the maximal reaction velocity, S is the surface area and KM is the
concentration for which the velocity extends halfway towards the maximum. In
this case of an intracellular binding site, the relevant variable is the concentration
QC/VC around the binding site of the transporter, inside the cell.
In other cases, the eﬄux pump possesses an extracellular binding site. Conse-
quently, transport is determined by the drug concentration, QA/VA, in the apical
compartment and the corresponding Michaelis-Menten expression is:
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Fig. 2. Structure of antibiotic CNV97100
J(QA) = S VMQA/VAKM + QA/VA . (6)
Both situations will be considered in this paper. For reasons of simplicity, we have
considered that the eﬄux pumps depend on concentration on one of the two sides of
the membrane (Ruiz-Garcia et al., 2002; Gonzalez-Alvarez et al., 2005). However,
new results suggest that the transporter binding site for the molecule is inside the
inner leaflet of the membrane (Hennessy and Spiers, 2007). If we consider the space
inside the phospholipid bilayer to be an additional volume with two permeable
walls on either side, the concentration in that volume would be between those in
the adjacent volumes.
In the following section, these approximate expressions will be compared with the
experimental data from (Gonzalez-Alvarez et al., 2005).
3 Results
Our mathematical treatment of the evolution equations has provided us with ex-
plicit expressions for the evolution over time of the amounts QA/B/C(t), Eqs.(2),and
the apparent permeability, Eqs.(3) and (4). In this section we intend to determine
the validity of our approach. Firstly, by comparing theoretical predictions with the
full results of numerical simulations of the evolution equations, we will show that
our approximate treatment has a range of validity that covers typical experimental
situations.
Next, once this validity has been established, we will use our approximation to
make comparisons to experimental data from an antibiotic (CNV97100, see fig. 2)
absorption study (Gonzalez-Alvarez et al., 2005). In this experiment a pH of 7.0
was used in both the apical and the basolateral chamber to avoid any bias due to
ionisation effects. If the pH were different in the two chambers it would be nec-
essary to include these effects into the model by estimating the fraction of ionised
and non ionised compound and to model separately the permeation of both species
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in both directions in each chamber. The unstirred water layer had not been con-
sidered to be the limiting diffusion step, an assumption justified by taking into
account the molecular weight and the lipophilicity of CNV97100. This had been
checked experimentally in situ in rats (Bermejo et al., 1999) and in vitro in Caco-2
cells (Bermejo et al., 2004). As a consequence the three compartment model with a
Michaelis-Menten-type flow was chosen to be an adequate picture of the underlying
processes.
Finally, we will determine the variation of the eﬄux ratio, the equilibrium concen-
trations and the characteristic time scales for absorption with the system parame-
ters.
3.1 Concentration evolution and binding site location
We obtained expressions for the equilibrium amounts QeqA/B/C and the constants
(A/B/C)(1/2/3) for non-linear transporters of the Michaelis-Menten type, in cases
of transport mediated by both intracellular and extracellular binding. The corre-
sponding expressions are summarised in table 4 of the Appendix as a function of
parameters of the model. Using the numerical values of those parameters as de-
rived in the absorption study of reference (Gonzalez-Alvarez et al., 2005), we can
extract precise numerical values for the equilibrium amounts QeqA/B/C and the con-
stants (A/B/C)(1/2/3). Those numerical values are also listed in table 4. Finally, the
numerical values of the time constants t1/2/3 are listed in table 1. Using these nu-
merical values, extracted from a real experiment and thus corresponding to a case
of interest, we now proceed to check the accuracy of our approximation. To this
end, we plotted in figures 3 and 4 (for two different initial conditions) the results of
the direct numerical integration 2 of Eqs.(1) and our approximation, Eqs.(2). The
most noticeable feature is that, at the scale of the figures, the two approaches are
nearly indistinguishable and, in fact, the difference is of the order of the thickness
of the lines. We conclude that our treatment provides a simple, yet very precise,
expression for the evolution of the amounts QA/B/C(t) and can be used instead of
the less transparent numerical integration of the equations.
Table 1 lists the apparent permeabilities and the resulting eﬄux ratios, PappBA /P
app
AB ,
as obtained from Eqs.(3-4) in the cases of internal and external binding site and
different initial concentrations. The analysis of the three time scales t1/2/3, listed
in the same table, shows that t2 is well below the time of the first measurement
(30min) for all cases studied and the duration of experiment (t ∼ 2 h) satisfies
t  t1, t3, hence validating the approximations that led to Eqs.(3-4). The same
analysis justifies the validity of the linear fit used in the experimental studies to
extract the apparent permeabilities from the data. To avoid overloading the paper
2 For this numerical integration we used a fourth-order Runge-Kutta algorithm with a time
step of 1s.
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Fig. 3. Time evolution of concentrations on either side of the cells and inside. Dotted
line: Numerical integration of Eq. (1). Continuous line: explicit solution Eq.(2). Param-
eters taken from (Gonzalez-Alvarez et al., 2005), intracellular binding site with Michaelis–
Menten dynamics (5) is considered. Initial concentration C0 = 7500µM is applied on the
basolateral side. Right graph: first hour amplified.
with too many results, we have omitted the time scales for basolateral loading since
they are of similar order.
To end the comparison with experimental data, we plot the results of the CNV97100
study in figure 5, superimposing on the data a line with a slope equal to the apparent
permeability from table 1 (multiplied by S C0). If the antibiotic is loaded apically
(top row in fig. 5) the prediction of the model is good for all initial concentrations.
If the loading is basolateral (bottom row); the prediction for low initial concen-
tration underestimates the measured slope. As a consequence, the predicted eﬄux
ratio differs from experiment at lower concentrations, which makes a more detailed
analysis of this difference necessary. The Michaelis-Menten kinetics used seem to
provide an insufficient representation of P-gp eﬄux at lower initial concentrations
when loaded basolaterally. The model underestimates the pump’s efficiency in a
basolateral to apical set up. We stress that our approximate solution still yields very
accurate results for the apparent permeabilities and that this observed difference is
a direct consequence of the model or the parameters used. To make this point clear,
we have plotted the result of the numerical integration of (1) for the lowest con-
centration of 50µM in figure 5. The deviation from the experimental data is clearly
observable in the case of basolateral loading of the drug. Considerations of other
eﬄux pathways in the P-gp transporter protein are found for example in (Acharya
et al., 2006).
3.2 Parameter dependence
Once we had determined the validity of our approach, we wished to use the ex-
plicit expressions to determine the dependence on the system parameters of some
quantities which are of experimental interest. Here lies one of the strengths of our
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Fig. 4. Same as figure 3, but initial concentration 50µM applied apically.
Table 1
Time scales (when loaded apically) and apparent permeabilities predicted for different ini-
tial concentrations and different models (internal/external binding site).
C0 binding t1 t2 t3 P
app
BA (cm s
−1) PappAB (cm s
−1)
PappBA
PappAB
7500 int 12.3h 6.38min 23.6h 6.70×10−6 6.37×10−6 1.05
ext 11.9h 6.67min 0.567h 6.80×10−6 4.12×10−6 1.65
5000 int 12.5h 6.27min 23.6h 6.73×10−6 6.26×10−6 1.07
ext 11.9h 6.67min 0.567h 6.86×10−6 3.97×10−6 1.73
1000 int 13.5h 5.59min 23.6h 6.88×10−6 5.57×10−6 1.24
ext 12.5h 6.70min 0.567h 7.18×10−6 3.10×10−6 2.32
50 int 13.8h 4.90min 23.6h 7.10×10−6 4.88×10−6 1.45
ext 15.7h 6.73min 0.567h 6.94×10−6 2.07×10−6 3.35
solution: In figure 6 we plot the characteristic time scale for absorption t1, the equi-
librium concentration ratio on both cell sides beq/aeq and the eﬄux ratio P
app
BA /P
app
AB
as a function of the clearances ClAC and ClCB, the pump parameters VM and KM and
the initial concentration of drug C0. Analytic formulas give access to these results
much easier than repetitive integration throughout parameter space plus extracting
the data from the resulting trajectories.
Again, for reasons of simplicity, we have limited our presentation to the case of a
secretory pump located apically with intracellular binding site; the best model ac-
cording to analysis by (Gonzalez-Alvarez et al., 2005). As observed in this figure,
an increase in the initial concentration C0 implies a decrease in the characteris-
tic time t1 from a finite value to a minimum value, limiting t1 to a certain range.
Raising C0 increases the equilibrium concentration ratio beq/aeq. Although this ra-
tio varies significantly, steady concentration in the basolateral site, beq, shows a
good linear dependence with C0 (not shown in the figure). Note that the eﬄux
ratio PappBA /P
app
AB also decreases with increasing initial concentration, a feature sup-
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Fig. 5. Antibiotic’s concentration on the receiving side. (Top: drug loaded in apical com-
partment, bottom: basolateral loading.) Experimental values are from CNV97100 study.
The solid line’s slope is the prediction from the theoretical solution (shown in table 1) for
intracellular binding, which was considered to be the model of best fit. The dashed line in
the graphs on the right shows the numerical integration of the full system (1).
ported by the experimental data, although the theoretical values deviate from the
experimental results at low concentrations, a fact already discussed in the previous
section. The clearance ClCB of the membrane where the pump is not situated has no
influence on the equilibrium concentration and eﬄux ratios, but an increase of ClCB
decreases the characteristic time t1, indicating a faster transport of the drug. On the
other hand, an increase in the clearance ClAC of the cell membrane where the pump
is located has the effect of decreasing the eﬄux ratio and increasing the equilibrium
concentration ratio. For large initial concentrations, C0 = 7500µM, the character-
istic time t1 shows interesting behaviour with ClAC since it first increases and then
decreases, indicating very slow drug absorption for some intermediate values of the
clearance.
At large concentrations, the three quantities analysed show small dependence with
respect to the pump parameters VM and KM, since the corresponding curves are
almost flat. This makes it difficult to extract from the data accurate values of the
pump parameters at those large concentrations. This suggests that lower concentra-
tions would allow for a better experimental determination of the pump parameters -
a practise used by experimentalists - however, we have to take into account, as dis-
cussed above, that the accuracy of the model might worsen with decreasing concen-
tration. In the graph, we have included negative values for VM, which is equivalent
to a change in the flow direction of the pump.
Apart from these considerations, analysis of parameter dependency is the first step
towards examining the propagation of errors into the experimentally available quan-
tities. For example, it is clear from figure 6 (third and fourth column), that small
differences in ClAC would be nearly unnoticed, due to the rather flat curve around
10
00.5
1
1.5
b  e
q 
/ a
eq
0
0.5
1
1.5
0
0.5
1
1.5
0
0.5
1
1.5
0
0.5
1
1.5
0
10
20
t 1
 
 
(h)
0
10
20
0
20
40
60
80
100
0
10
20
0
10
20
-1e-11 0 1e-11
V
 M (mol/(cm
2
s))
0
1
2
3
P B
A
ap
p /P
A
Ba
pp
0 1 2
K
 M  (µmol/cm
3)
0
1
2
3
0 10 20
Cl
 AC  (10
-5
 cm
3/s)
0
1
2
3
0 10 20
Cl
 CB  (10
-5
 cm
3/s)
0
1
2
3
0 2 4 6 8 10
C0(mol/cm
3)
1
1.5
2
2.5
3
Fig. 6. Secretory pump, intracellular binding site - Top and middle: equilibrium concen-
tration ratio (basolateral/apical) and characteristic time (both for apical loading), bottom:
eﬄux ratio PappBA /P
app
AB . Dependence on VM and KM (transporter parameters) and clearances
ClAC/CB. Continuous line: C0 = 7500µM, dot-dashed line: C0 = 50µM. On the very right:
dependence on initial concentration C0. Arrows on top mark the experimentally derived
value. (Values for the respectively fixed parameters taken from table 2.)
its measured value (marked by the black arrow on top of the figures). On the other
hand, a small change in ClCB yields a big variation of time scale t1. More detailed
investigations of errors and how they bias the results have been left aside for sub-
sequent investigations.
4 Discussion
Three-compartment models are widely used in drug absorption studies. The one
treated here consists of a linear part, representing passive absorption (for example
through cell membranes), and a non-linear part which models other means of trans-
port, such as ABC-transporter proteins embedded into the cell membrane. In this
work we have shown a way to transform this model into the picture of a ball in a
well (fig. 7), which is a general form of equations facilitating analysis of mathe-
matical structure. The lowest point of the “well” gives the value of the equilibrium
concentration after saturation of the process. With an adequate approximation,
one can derive the absorption profile as the sum of three exponentials and identify
their characteristic time scales dividing the process into phases of linear change,
non-linear fluxes and saturation. In the phase of a near-linear profile we can provide
explicit expressions for the apparent permeability, a quantity usually measured in
experiments.
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These are general results which we used on a showcase system, where the non-
linear transport is described by a Michaelis-Menten profile - a common model of
transporter proteins (Sharma et al., 2002; Volk and Schneider, 2003; Mizuarai et al.,
2004). The approach presented in this paper make eﬄux ratio and time scales ac-
cessible. Both apical and basolateral drug loading can be treated by changing the
initial conditions; we furthermore considered the possibilities of intracellular as
well as extracellular binding sites. We analysed the importance of each physiolog-
ical parameter in a wide range of values.
The presented results may contribute to a better understanding of the absorption
process and to explaining differing observations in identical experimental setups
from a more fundamental basis. Knowledge of parameter dependencies, a funda-
mental analysis of errors (confidence interval) and their consequences becomes
possible. This has been left aside for later studies. The most promising experimen-
tal setups can furthermore be predicted by treating a newly proposed model in the
same way.
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5 Appendix
We will now give an overview of the used mathematical methods used and show
the explicit solutions in the following subsections.
The conservation law Eq. (1d) reduces the number of independent variables from
three to two concentrations. In other words, the system described by first-order
differential equations (1) only has two degrees of freedom. This implies that it can
be replaced by a single differential equation of second order of the form:
x¨ = −Γ (x) x˙ + F(x). (7)
Variable x represents a rescaled concentration in one of the compartments (the cel-
lular compartment if J depends on QC, as when using (5), and the apical compart-
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Fig. 7. Visualisation of the particle-potential picture. The position of the “ball” represents
the concentration which will eventually end up in the minimum.
ment ifJ depends on QA, as when using (6)); the speed, x˙, and acceleration, x¨, are,
respectively, the first and second derivatives of x with respect to a rescaled time s,
and Γ(x) and F(x) are functions to be described below.
A qualitative understanding of these dynamics can be had by acknowledging that
the previous equation corresponds to the equation of motion (Newton’s second law)
for the position x of a particle of unit mass upon which a force F(x) and a friction,
proportional to the particle speed x˙ act. The force F(x) and the friction coefficient
Γ(x) contain all of the parameters of the system as well as the particular form of the
non-linear flux (eqs. (10)).
If we now introduce the potential function V(x) from which the force derives as
F(x) = −dV
dx
, the evolution of x can be visualised as the relaxation of a ball rolling
downwards within a well of shape V(x) under the combined effects of gravity and
friction. It is known from mechanics that the particle will eventually stop at the
minimum of the potential (stable equilibrium state) and that relaxation towards this
final state will proceed via damped oscillations or monotonously, depending on
the relative strength of the friction and potential contributions. Figure 7 visualises
this ball-in-a-well approach. For very general non-linear transporters, including the
Michaelis-Menten form, Eqs.(5,6), used in this paper, the corresponding potential
function V(x) displays a single minimum, although its exact shape depends both on
the linear and the non-linear terms in Eqs. (1).
Once this mechanical simile has been realised, an approximation appears quite nat-
ural: the potential V(x) is replaced by the parabolic approximation around its mini-
mum, equilibrium, value xeq, i.e. approximate V(x) ≈ V(xeq)+ω22 (x−xeq)2. Similarly,
the friction coefficient is replaced by its value at this minimum Γ(x) ≈ Γ(xeq) = Γeq.
With these approximations, Newton’s equation (7) becomes the linear equation
x¨ = −Γeq x˙ − ω2(x − xeq), which describes the damped pendulum of frequency ω.
The solution of this equation, as found in many elementary books of mechanics,
can be written as the sum of exponential functions of time. One can then undo the
change of variables and write the solution in full as done above (eqs. 2)
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5.1 Parameters and simplifications for three-compartment system
The conservation law (1d) allows the elimination of one of the three equations of the
set (1a-1c). We have chosen to eliminate either QA or QC, depending on whether the
non-linearity depends on QC or QA, respectively. More precisely: if J = J(QC),
we define the dimensionless normalised concentration x(t) =
QC(t)
VCN where N is a
normalisation constant with units of concentration to be specified later; in the other
case, when J = J(QA), we define x(t) = QA(t)VAN . In both cases, we also define
y(t) =
QB(t)
VBN . The initial drug concentration C0 = Q0/VI (being VI = VA or VI = VB
according to whether the drug is initially loaded on the apical or the basolateral
volume, respectively) is also rescaled to c0 =
C0
N . We finally define a rescaled
dimensionless time variable s =
ClCB
VB
t. It turns out that, with these definitions, the
resulting two-degree system can be written in the common form:
x˙(s) =
dx(s)
ds
= a11x + a12y + a13 + j(x) (8a)
y˙(s) =
dy(s)
ds
= a21x + a22y + a23. (8b)
with j =
VB
ClCBVANJ(QA) in one case, and j = −
VB
ClCBVCNJ(QC) in the other. The
dimensionless constants ai j depend on the clearances, volumes, overall concentra-
tion, as specified in table 3.
By differentiating x˙(s) with respect to s using Eq.(8a) and, in the resulting expres-
sion, replacing y˙(s) by Eq.(8b) and y(s) by its isolation from Eq.(8a), we get the
form (7):
x¨ = −Γ (x) x˙ + F(x), (9)
with friction coefficient Γ(x) and force F(x) given by:
Γ (x) = Γ0 − j′(x), F(x) = α − βx − a22 j(x). (10)
Γ0, α and β are dimensionless, positively-defined constants, whose relation to the
coefficients ai j are also detailed in table 3.
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5.2 Coefficients in case of Michaelis-Menten eﬄux transporter
This presentation has so far been very general. In the case of the Michaelis-Menten
form for the non-linear eﬄux transport function J , formulas (5) or (6), we identify
KM as a characteristic concentration and simply adopt the normalisation constant
N = KM. Therefore the current is
j(x) = γ
x
1 + x
(11)
where γ is written up in table 3. The friction coefficient and force are:
Γ(x) = Γ0 − γ(1 + x)2 , F(x) = α − βx − γa22
x
1 + x
. (12)
Note that the initial concentration C0 is contained only in α and that the influence
of the eﬄux transporter is found completely in γ. Γ0, α and β are independent of
the location of the pump. The values used for numerical calculations are taken from
(Gonzalez-Alvarez et al., 2005) and can be seen in table 2.
The potential from which the force F(x) = −dV(x)dx derives is:
V(x) = (−α + γa22)x + β2 x
2 − γa22 ln(1 + x) . (13)
The equilibrium concentration xeq is the minimum of the potential, obtained by set-
ting the force in Eq.(12) equal to zero. In the present case of a Michaelis-Menten
type non-linearity, the solution is obtained without using any further approxima-
tions or simplifications other than stated for the original model:
xeq =
α − β − γa22 +
√
4αβ + (α − β − γa22)2
2β
. (14)
Inserted into (8b) the equilibrium value for y(s) is the solution of y˙(s) = 0:
yeq = −a21xeq + a23a22 (15)
Through the conservation law one gets zeq:
zeq =
Q0
VzN − xeq
Vx
Vz
− yeq VBVz , (16)
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Fig. 8. Continuous line: Original potential Eq. (13), dashed line: approximated parabola.
For different amounts of loaded drug. Differences are of the order of the line width.
where, to unify notation, we have labelled the volumes’ meaning Vx = VC and
Vz = VA for intracellular binding, and Vx = VA and Vz = VC for extracellular
binding.
5.3 The linearised model
The potential V(x) , Eq. (13), has a single minimum and it can be approximated by
a parabola around this minimum V(x) = Veq+ 12V
′′
eq
(
x − xeq
)2
. The second derivative
with respect to x is:
V ′′
(
xeq
)
= ω2 = β +
a22 γ(
1 + xeq
)2 . (17)
The approximated and original potentials are drawn in figure 8 in the case of apical
loading of a system with intracellular binding site. From this figure, it can be seen
that the parabolic form constitutes an excellent approximation for a wide range of
initial concentrations C0.
Furthermore, we also approximate the friction coefficient Γ(x) by its value at equi-
librium Γeq = Γ0 − γ(1+xeq)2 . The resulting linear differential equation x¨ = −Γeq x˙ −
ω2(x − xeq) has the solution (Boyce and DiPrima, 2001):
x(s) = C˜1e−s/τ1 + C˜2e−s/τ2 + xeq (18)
with time constants:
τ1 =
2
Γeq −
√
Γ2eq − 4ω2
and τ2 =
2
Γeq +
√
Γ2eq − 4ω2
(19)
The coefficients C˜1 and C˜2 are determined by the initial conditions x0 and x˙0, the
latter being determined through Eq.(8b) by x0 and y0 as x˙0 = a11x0+a12y0+a13 j(x0).
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The resulting formulas are summarised in table 5. The initial values x0 and y0 de-
pend on the particular model used. For example, for intracellular binding we have
x0 =
QC(t=0)
VC KM
= 0 and y0 =
QB(t=0)
VBKM
. This latter value, in turn, has to be adjusted ac-
cording to where the drug is loaded: for apical loading y0 = 0, while for basolateral
loading y0 = C0KM . Note that τ1 and τ2 will be complex if Γeq < 2ω. In this case the
system would relax to the steady state by performing damped oscillations. How-
ever, for the values of the parameters drawn from experiments, this case does not
arise, τ1 and τ2 are positive real numbers and the decay to the equilibrium state is
governed by real exponentials.
The time evolution of y can be obtained by a direct integration of the linear equation
(8b):
y(s) = ea22 s
y0 +
s∫
0
ds′ e−a22 s
′ (
a21x(s′) + a23
) (20)
which yields
y(s) = D˜1e−s/τ1 + D˜2e−s/τ2 + D˜3e−s/τ3 + yeq . (21)
with a new time constant:
τ3 = − 1a22 (22)
and coefficients D˜1/2/3, whose relation to other constants is detailed in table 5. The
evolution of z(s) is obtained by means of the conservation law. Finally, when we
undo the changes of variables we obtain coefficients as given in table 4 and together
with Eq.(19) we derive Eqs. (2). It is worth recalling that the time scales in real units
are
t1 =
VB
ClCB
τ1 , t2 =
VB
ClCB
τ2 , t3 =
VB
ClCB
τ3 . (23)
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Table 2
Experimental parameters drawn from (Gonzalez-Alvarez et al., 2005) used for the calcula-
tions.
Parameter Measured Value
ClAC 14.49 × 10−5cm3/s
ClCB 3.528 × 10−3cm3/s
VM 6.17 × 10−12mol/(cm2s)
KM 0.376mol/cm3
S 4.2cm2
VA 2cm3
VB 3cm3
VC 0.0738cm3
Table 3
Coefficients for equations (8) using parameter values from (Gonzalez-Alvarez et al., 2005).
Parameter INTRAcellular numerical EXTRAcellular numerical
a11 −
[
VB
VC
+
ClAC
ClCB
(
VB
VC
+
VB
VA
)]
-213.8 −ClACClCB
(
VB
VC
+
VB
VA
)
-173.1
a12
VB
VC
(
1 − ClACClCB
VB
VA
)
-209.8 −ClACClCB
V2B
VAVC
-250.4
a13
ClAC
ClCB
VBVI
VAVC
c0 2.220×108VIC0 ClACClCB
VBVI
VAVC
c0 2.220×108VIC0
a21 1 1 −VAVC -27.10
a22 −1 -1 −
(
VB
VC
+ 1
)
-41.65
a23 0 0 c0 VIVC 3.604×108VIC0
γ − S VMClCBKM
VB
VC
-79.41 S VMClCBKM
VB
VA
2.930
Γ0 −a11 − a22 = VBVC +
ClAC
ClCB
(
VB
VC
+
VB
VA
)
+ 1 214.8
α a12a23 − a13a22 = ClACClCB
VBVI
VAVC
c0 2.220×108VIC0
β a11a22 − a12a21 = ClACClCB
VB
VAVC
(VA + VB + VC) 423.6
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